These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 29604045)

  • 1. Understanding Hematological Toxicities Using Mathematical Modeling.
    Fornari C; O'Connor LO; Yates JWT; Cheung SYA; Jodrell DI; Mettetal JT; Collins TA
    Clin Pharmacol Ther; 2018 Oct; 104(4):644-654. PubMed ID: 29604045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospects for eradication of therapy-induced myelosuppression.
    Ventura G; Spitzer G; Hester J; Deisseroth A
    Bone Marrow Transplant; 1990 Jan; 5 Suppl 1():41-2. PubMed ID: 1969309
    [No Abstract]   [Full Text] [Related]  

  • 3. Hematologic complications of cancer chemotherapy.
    Hoagland HC
    Semin Oncol; 1982 Mar; 9(1):95-102. PubMed ID: 7071611
    [No Abstract]   [Full Text] [Related]  

  • 4. Mechanistic Investigation of Bone Marrow Suppression Associated with Palbociclib and its Differentiation from Cytotoxic Chemotherapies.
    Hu W; Sung T; Jessen BA; Thibault S; Finkelstein MB; Khan NK; Sacaan AI
    Clin Cancer Res; 2016 Apr; 22(8):2000-8. PubMed ID: 26631614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone Marrow Micro-Environment in Normal and Deranged Hematopoiesis: Opportunities for Regenerative Medicine and Therapies.
    Sarkaria SM; Decker M; Ding L
    Bioessays; 2018 Mar; 40(3):. PubMed ID: 29384206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Review on experimental studies of Chinese drugs in antagonizing bone marrow inhibition caused by chemicals].
    Yang T; Deng D
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 1999 Aug; 19(8):506-8. PubMed ID: 11783234
    [No Abstract]   [Full Text] [Related]  

  • 7. Long-term bone marrow damage in experimental systems and in patients after radiation or chemotherapy.
    Testa NG; Hendry JH; Molineux G
    Anticancer Res; 1985; 5(1):101-10. PubMed ID: 3888044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemotherapy-induced myelosuppression.
    Maxwell MB; Maher KE
    Semin Oncol Nurs; 1992 May; 8(2):113-23. PubMed ID: 1621002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benzene-induced hematotoxicity and bone marrow compensation in B6C3F1 mice.
    Farris GM; Robinson SN; Gaido KW; Wong BA; Wong VA; Hahn WP; Shah RS
    Fundam Appl Toxicol; 1997 Apr; 36(2):119-29. PubMed ID: 9143481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and application of in vitro models of hematopoiesis to drug development.
    Deldar A; Stevens CE
    Toxicol Pathol; 1993; 21(2):231-40. PubMed ID: 7692585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preclinical Characterization of G1T28: A Novel CDK4/6 Inhibitor for Reduction of Chemotherapy-Induced Myelosuppression.
    Bisi JE; Sorrentino JA; Roberts PJ; Tavares FX; Strum JC
    Mol Cancer Ther; 2016 May; 15(5):783-93. PubMed ID: 26826116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Latent hematopoietic stem cell toxicity associated with protracted drug administration.
    Keyes KA; Segovia JC; Bueren JA; Parchment RE; Albella B
    Exp Hematol; 2001 Mar; 29(3):286-94. PubMed ID: 11274755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Stem cell kinetics of bone marrow in relation to cytostatic treatment].
    Laerum OD
    Tidsskr Nor Laegeforen; 1971 Jun; 91(16):1207-9 passim. PubMed ID: 4935674
    [No Abstract]   [Full Text] [Related]  

  • 14. Stem cell maneuvers target bone marrow toxicity.
    Randal J
    J Natl Cancer Inst; 1999 Sep; 91(18):1530-2. PubMed ID: 10491422
    [No Abstract]   [Full Text] [Related]  

  • 15. An in vitro quantitative systems pharmacology approach for deconvolving mechanisms of drug-induced, multilineage cytopenias.
    Wilson JL; Lu D; Corr N; Fullerton A; Lu J
    PLoS Comput Biol; 2020 Jul; 16(7):e1007620. PubMed ID: 32701980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of stem cell factor on in vitro erythropoiesis in patients with bone marrow failure syndromes.
    Alter BP; Knobloch ME; He L; Gillio AP; O'Reilly RJ; Reilly LK; Weinberg RS
    Blood; 1992 Dec; 80(12):3000-8. PubMed ID: 1281683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo biologic effects of PIXY321, a synthetic hybrid protein of recombinant human granulocyte-macrophage colony-stimulating factor and interleukin-3 in cancer patients with normal hematopoiesis: a phase I study.
    Vadhan-Raj S; Broxmeyer HE; Andreeff M; Bandres JC; Buescher ES; Benjamin RS; Papadopoulos NE; Burgess A; Patel S; Plager C; Hittelman WN; McAlister I; Garrison L; Williams DE
    Blood; 1995 Sep; 86(6):2098-105. PubMed ID: 7662957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thioredoxin mitigates radiation-induced hematopoietic stem cell injury in mice.
    Sundaramoorthy P; Wang Q; Zheng Z; Jiao Y; Chen BJ; Doan PL; Chao NJ; Kang Y
    Stem Cell Res Ther; 2017 Nov; 8(1):263. PubMed ID: 29141658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hemoprotection with dicarbamine: shielding of bone marrow hemopoietic cells from apoptosis and induction of cell differentiation in myelosuppressive effect of cyclophosphamide].
    Raĭkhlin NT; Bukaeva IA; Sitdikova SM; Nebol'sin VE
    Vopr Onkol; 2011; 57(4):497-500. PubMed ID: 22191241
    [No Abstract]   [Full Text] [Related]  

  • 20. The mechanisms involved in the impairment of hematopoiesis after autologous bone marrow transplantation.
    Domenech J; Roingeard F; Binet C
    Leuk Lymphoma; 1997 Jan; 24(3-4):239-56. PubMed ID: 9156654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.